NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Press Release

NuVasive to Report Second Quarter 2004 Financial Results on July 28, 2004

SAN DIEGO, Jul 8, 2004 /PRNewswire-FirstCall via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that it will release second quarter financial results for the period ended June 30, 2004 after market close on Wednesday, July 28, 2004 with an accompanying conference call at 5:00 p.m. EDT / 2:00 p.m. PDT.

A live Webcast of the conference call will be available online from the investor relations page of the Company's corporate Web site at The dial-in numbers are (800) 921-9431 for domestic callers, and (973) 935-8505 for international. The reservation number for both is 4956743. After the live Webcast, the call will remain available on NuVasive's Web site,, through August 25, 2004. In addition, a telephonic replay of the call will be available until August 11, 2004. The replay dial-in numbers are (877) 519-4471 for domestic callers and (973) 341-3080 for international callers. Please use reservation code 4956743.

About NuVasive

NuVasive is a medical device company focusing on the design, development and marketing of products for use in minimally disruptive surgical treatments for the spine. NuVasive's Maximum Access Surgery (MAS(TM)) product platform includes the NeuroVision(R) nerve avoidance system, MaXcess(TM) spine access system, and specialized implants. NuVasive also offers classic fusion implant products for use in spine surgery.

Kevin C. O'Boyle
Chief Financial Officer
NuVasive, Inc.

Stephanie Carrington/Greg Tiberend
The Ruth Group

NuVasive, Inc.
Web Site: